A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14221 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Chetan Jeurkar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cyclophosphamide, Graft vs Host Disease, Unrelated Donors, Peripheral Blood Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Posttransplant cyclophosphamide (PtCy) has been shown to decrease post‐hematopoietic stem cell transplant acute and chronic graft‐versus‐host disease (GVHD). In this study, PtCy was used in 44 patients along with mycophenolate and tacrolimus with HLA matched (29) and mismatched (15) unrelated donors to determine the impact of graft content on outcome; thus, all patients had flow cytometric analysis of their graft content including the number of B cells, NK cells, and various T cell subsets. Higher γδ T cell dose was associated with the development of acute GVHD ( p = .0038). For PtCy, further studies of the cell product along with further graft manipulation, such as selective γδ T cell depletion, could potentially improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: William O'Hara, Pierluigi Porcu, John L Wagner
Zitieren
APA
Jeurkar, C., Leiby, B., Rashid, S., Gergis, U., Grossso, D., Carabasi, M., Filicko-O'Hara, J., O'Hara, W., Klumpp, T., Porcu, P., Flomenberg, N., & Wagner, J. L. (2024). A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose. European Journal of Haematology. https://doi.org/10.1111/ejh.14221
Vancouver
Jeurkar C, Leiby B, Rashid S, Gergis U, Grossso D, Carabasi M, et al. A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose. European Journal of Haematology. 2024. doi:10.1111/ejh.14221
BibTeX
@article{Jeurkar2024,
author = {Jeurkar, Chetan and Leiby, Benjamin and Rashid, Shaik and Gergis, Usama and Grossso, Dolores and Carabasi, Matthew and Filicko-O'Hara, Joanne and O'Hara, William and Klumpp, Thomas and Porcu, Pierluigi and Flomenberg, Neal and Wagner, John L},
title = {A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14221}
}
EUVIMED